FILE - In this Tuesday, May 11, 2021 file photo, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research in the Food and Drug Administration, testifies during a Senate health, education, labor, and pensions hearing to examine an update from federal officials on efforts to combat COVID-19 on Capitol Hill in Washington. On Friday, Sept. 10, 2021, Marks urged parents to be patient, saying the agency will rapidly evaluate vaccines for 5- to 11-year-olds as soon as it gets the needed data. (Jim Lo Scalzo/Pool via AP)
The Food and Drug Administration’s vaccine chief is pledging to rapidly evaluate COVID-19 vaccines for younger kids — as soon as the studies are in. Dr. Peter Marks tells The Associated Press he is “very, very hopeful” that vaccinations for 5- to 11-year-olds will be underway by year’s end.
One company, Pfizer, is expected to turn over its study results by the end of September and Marks said FDA hopes to analyze them in a matter of weeks. He said the agency won’t cut corners. Marks spoke with the AP on Friday.
Saudi Arabia, 20 Years After 9/11: ‘A country in the making’